Sepracor-Looks very promising Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: wolfdog2 who wrote (2913)	5/22/1999 7:40:00 PM
From: GENE KRANE	Read Replies (1) of 10280

yesterday may 21, 1999, john hopkins medical center anounced a drug in late stage of clinacal testing, a drug that can bind iga (immuno-golbulins)which is responsible for allergies, also they found to their suprise as you diminish iga levels the number of receptors also decreases, this is an important find for allergy-immunology ! this new drug is it given by mouth or injection ? does anyone have more information on this topic ? sepracor is very heavy invested into allergy drugs; if this new drug is by mouth it could affect future investments ICE drugs !

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next